Targeting immunosuppressive macrophages by CSRP2-regulated CCL28 signaling sensitizes hepatocellular carcinoma to lenvatinib.
通过 CSRP2 调节的 CCL28 信号通路靶向免疫抑制性巨噬细胞,可使肝细胞癌对乐伐替尼敏感。
期刊:Journal for ImmunoTherapy of Cancer
影响因子:10.6
doi:10.1136/jitc-2025-012201
Chen Changzhou, Su Sheng, Wang Pengcheng, Ye Xinming, Yu Songyang, Gong Yu, Li Zehuan, Li Jia, Hu Zhiqiang, Huang Xiaowu